Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.

Alzheimer disease and associated disorders - 1 Jan 2000

Chao Serena, Roberts J Scott, Marteau Theresa M, Silliman Rebecca, Cupples L Adrienne, Green Robert C

Abstract excerpt

Risk information for Alzheimer disease (AD) may be communicated through susceptibility gene disclosure, even though this is not currently in clinical use. The REVEAL Study is the first randomized clinical trial of risk assessment for AD with apolipoprotein E (APOE) genotype and numerical risk est...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to APOE gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Genotype

Share to Health Behavior

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 18317253
DOI: 10.1097/WAD.0b013e31815a9dcc
PMCID: PMC2483341

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18317253-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.PMID 18317253Read ↗

Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.Semantic proximity Read ↗

Disclosure of APOE genotype for risk of Alzheimer's disease.Semantic proximity Read ↗

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.Semantic proximity Read ↗

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.Semantic proximity Read ↗

Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.Semantic proximity Read ↗

Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.Semantic proximity Read ↗

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Semantic proximity Read ↗

Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.Semantic proximity Read ↗

Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.Semantic proximity Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.Semantic proximity Read ↗

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.